IP Library › Assignment 057471/0847
Patent Assignment
Reel/Frame 057471/0847

Change of Name

Recorded: 2021-09-10 Pages: 5
Assignor
NEUVIVA, INC.
Executed: 2021-06-01
Assignee
NEUVIVO, INC.
798 LOYOLA DRIVE, LOS ALTOS, CALIFORNIA, 94024
Covered Properties (7)
Treatment of Neurodegenerative Disease with Sodium Chlorite
Application: 15/772,317 →
Publication: US 2019/0060359
Chlorite Formulations, and Methods of Preparation and Use Thereof
Patent: 9,839,650 →
Application: 14/996,876 →
Publication: US 2016/0129040
Chlorite Formulations and Methods of Preparation and Use Thereof
Patent: 8,231,856 →
Application: 13/103,195 →
Publication: US 2012/0015051
Chlorite Formulations and Methods of Preparation and Use Thereof
Patent: 8,501,244 →
Application: 13/249,123 →
Publication: US 2012/0021070
Chlorite Formulations and Methods of Preparation and Use Thereof
Patent: 9,266,734 →
Application: 13/249,098 →
Publication: US 2012/0021069
Treatment of Macrophage-Related Disorders
Patent: 9,579,346 →
Application: 14/271,054 →
Publication: US 2015/0037320
Chlorite Formulations, and Methods of Preparation and Use Thereof
Patent: 8,067,035 →
Application: 11/614,859 →
Publication: US 2007/0145328
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 27, 2007
From: BOULANGER, WILLIAM; AZHIR, ARASTEH ARI
To: TAIJI BIOMEDICAL, INC.
Reel/Frame 019072/0145 →
Change of Name Jun 17, 2010
From: TAIJI BIOMEDICAL, INC.
To: NEURALTUS PHARMACEUTICALS, INC.
Reel/Frame 024554/0011 →
Change of Name Oct 13, 2011
From: TAIJI BIOMEDICAL, INC.
To: NEURALTUS PHARMACEUTICALS, INC.
Reel/Frame 027059/0956 →
Assignment of Assignor's Interest Oct 13, 2011
From: BOULANGER, WILLIAM; AZHIR, ARASTEH ARI
To: TAIJI BIOMEDICAL, INC.
Reel/Frame 027056/0390 →
Assignment of Assignor's Interest May 28, 2014
From: MCGRATH, MICHAEL S.; AZHIR, ARASTEH ARI
To: NEURALTUS PHARMACEUTICALS, INC.
Reel/Frame 032974/0520 →
Corrective Assignment to Correct the Fact That Arasteh Ari Azhir Is the Only One Who Assigns to Neuraltus Pharmaceuticals, Inc. Previously Recorded on Reel 032974 Frame 0520. Assignor(S) Hereby Confirms the Arasteh Ari Azhir Is the Only One Who Assigns to Neuraltus Pharmaceuticals, Inc.. May 29, 2014
From: AZHIR, ARASTEH ARI
To: NEURALTUS PHARMACEUTICALS, INC.
Reel/Frame 033053/0729 →
Corrective Assignment to Correct the Michael S. Mcgrath Assigns Only to the Regents of the University of California Previously Recorded on Reel 032974 Frame 0520. Assignor(S) Hereby Confirms the Michael S. Mcgrath Assigns to the Regents of the University of California. May 29, 2014
From: MCGRATH, MICHAEL S.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 033053/0801 →
Corrective Assignment to Correct the Execution Date by the Inventor Arasteh Ari Azhir Previously Recorded on Reel 033053 Frame 0729. Assignor(S) Hereby Confirms the Document and Execution Date of the Assignment Signed by Arasteh Ari Azhir Is August 19, 2011. Feb 27, 2015
From: AZHIR, ARASTEH ARI
To: NEURALTUS PHARMACEUTICALS, INC.
Reel/Frame 035109/0159 →
Assignment of Assignor's Interest Jan 30, 2017
From: BOULANGER, WILLIAM; AZHIR, ARASTEH ARI
To: TAIJI BIOMEDICAL, INC.
Reel/Frame 041126/0221 →
Change of Name Jan 30, 2017
From: TAIJI BIOMEDICAL, INC.
To: NEURALTUS PHARMACEUTICALS, INC.
Reel/Frame 041565/0302 →
Assignment of Assignor's Interest Dec 27, 2019
From: NEURALTUS PHARMACEUTICALS, INC.
To: NORVIEL, VERNON A.
Reel/Frame 051380/0353 →
Assignment of Assignor's Interest Dec 27, 2019
From: NEURALTUS PHARMACEUTICALS, INC.
To: NORVIEL, VERNON A.
Reel/Frame 051380/0418 →
Assignment of Assignor's Interest Aug 6, 2020
From: NORVIEL, VERNON A.
To: NEUVIVA, INC.
Reel/Frame 053425/0719 →
Assignment of Assignor's Interest Aug 6, 2020
From: NORVIEL, VERNON A.
To: NEUVIVA, INC.
Reel/Frame 053425/0733 →
Assignment of Assignor's Interest Jan 4, 2023
From: MCGRATH, MICHAEL S.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 062272/0130 →